Literature DB >> 2249603

Characteristics of cranial nerve palsies in diabetic patients.

K Watanabe1, R Hagura, Y Akanuma, T Takasu, H Kajinuma, N Kuzuya, M Irie.   

Abstract

The incidence of palsy in the third, sixth and seventh cranial nerves was studied with regard to central nervous system involvement in diabetic patients. Among 1961 diabetic patients, 19 (0.97%) demonstrated cranial nerve palsies. Nine out of these 19 patients showed facial palsy; 6 palsy of the oculomotor nerve; 2 palsy of the abducent nerve; and 3 both oculomotor and abducent nerve palsies. In contrast, only 5 out of 3841 non-diabetic patients (0.13%) had any cranial nerve palsies; all 5 were cases of facial palsy. The incidence of cranial palsies in diabetic patients was significantly higher than that in non-diabetic patients (P less than 0.01). Concerning age, sex, the state of glycemic control, diabetic complications and method of treatment, there were no differences disclosed in the diabetic patients with cranial nerve palsy. The incidences of diabetic complications were compared between the patients with facial palsy and those with ophthalmoplegia. Only one out of 9 patients with facial palsy (11%) had diabetic complications, whereas 7 out of 10 patients with ophthalmoplegia (70%) demonstrated diabetic complications and the difference was significant. Thus ophthalmoplegia appears to be more closely related to diabetic metabolism while facial palsy is less strongly correlated with diabetes.

Entities:  

Mesh:

Year:  1990        PMID: 2249603     DOI: 10.1016/0168-8227(90)90077-7

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  14 in total

Review 1.  Focal and multifocal neuropathies.

Authors:  Rayaz A Malik
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 2.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

3.  Comprehensive Review of the Effects of Diabetes on Ocular Health.

Authors:  Kathryn Skarbez; Yos Priestley; Marcia Hoepf; Steven B Koevary
Journal:  Expert Rev Ophthalmol       Date:  2010-08-01

4.  Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies.

Authors:  D Greco; F Gambina; M Pisciotta; M Abrignani; F Maggio
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

5.  Facial Palsy, Radiographic and Other Workup Negative: FROWN.

Authors:  Jacqueline J Greene; Reza Sadjadi; Nate Jowett; Tessa Hadlock
Journal:  Neurol Clin Pract       Date:  2021-10

Review 6.  The spectrum of diabetic neuropathies.

Authors:  Jennifer A Tracy; P James B Dyck
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-02       Impact factor: 1.784

Review 7.  Ocular associations of diabetes other than diabetic retinopathy.

Authors:  V Swetha E Jeganathan; Jie Jin Wang; Tien Yin Wong
Journal:  Diabetes Care       Date:  2008-09       Impact factor: 19.112

8.  Painful ophthalmoplegia with normal cranial imaging.

Authors:  Chih-Hsien Hung; Kuo-Hsuan Chang; Chun-Che Chu; Ming-Feng Liao; Hong-Shiu Chang; Rong-Kuo Lyu; Yi-Ming Wu; Yao-Liang Chen; Chiou-Lian Lai; Hsiao-Jung Tseng; Long-Sun Ro
Journal:  BMC Neurol       Date:  2014-01-09       Impact factor: 2.474

9.  Acupuncture for the Treatment of Oculomotor Paralysis: A Pilot Randomised Controlled Trial.

Authors:  Jia-Qi Bi; Wei Li; Qi Yang; Bao-Lin Li; Qing-Gang Meng; Yu-Fu Liu
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-24       Impact factor: 2.629

10.  Assessment of the prevalence and risk factors of ophthalmoplegia among diabetic patients in a large national diabetes registry cohort.

Authors:  Eman S Al Kahtani; Rajiv Khandekar; Khalid Al-Rubeaan; Amira M Youssef; Heba M Ibrahim; Ahmed H Al-Sharqawi
Journal:  BMC Ophthalmol       Date:  2016-07-22       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.